|
MBTPS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.373600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.469630E-01 |
| Normal-vs-Stage2 |
8.150600E-01 |
| Normal-vs-Stage3 |
7.139800E-01 |
| Normal-vs-Stage4 |
7.956400E-01 |
| Stage1-vs-Stage2 |
4.720000E-01 |
| Stage1-vs-Stage3 |
1.420600E-01 |
| Stage1-vs-Stage4 |
1.676580E-01 |
| Stage2-vs-Stage3 |
6.244200E-01 |
| Stage2-vs-Stage4 |
6.916600E-01 |
| Stage3-vs-Stage4 |
9.375200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.122600E-01 |
| Normal-vs-AfricanAmerican |
7.437400E-03 |
| Normal-vs-Asian |
2.643000E-01 |
| Caucasian-vs-AfricanAmerican |
2.383300E-04 |
| Caucasian-vs-Asian |
6.421200E-01 |
| AfricanAmerican-vs-Asian |
3.579900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.620200E-01 |
| Normal-vs-Female |
3.479800E-01 |
| Male-vs-Female |
4.573600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.166400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.053200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.399600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.234000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.885000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.252400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.793800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.711600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.895800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.250800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.813230E-01 |
| Normal-vs-Grade 2 |
1.425010E-01 |
| Normal-vs-Grade 3 |
9.416200E-01 |
| Normal-vs-Grade 4 |
2.562600E-01 |
| Grade 1-vs-Grade 2 |
7.412200E-01 |
| Grade 1-vs-Grade 3 |
3.739600E-01 |
| Grade 1-vs-Grade 4 |
1.552190E-01 |
| Grade 2-vs-Grade 3 |
1.567590E-01 |
| Grade 2-vs-Grade 4 |
3.294000E-02 |
| Grade 3-vs-Grade 4 |
2.273200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.556300E-02 |
| Normal-vs-ccB subtype |
4.932200E-01 |
| ccA subtype-vs-ccB subtype |
3.268200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.180600E-01 |
| Normal-vs-N1 |
8.528000E-01 |
| N0-vs-N1 |
9.630800E-01 |
|
|
